Abstract: Next-generation sequencing technology has made genetic testing for cancer risk more comprehensive, faster and cheaper than ever before. Yet questions remain about the impact of widespread genetic testing on cancer patients and their relatives, in terms of treatment decision-making and quality of life. I will discuss recent progress and ongoing research in this area.
Center for Bioethics and Social Sciences in MedicineGenetic Testing for Cancer Risk: The Impact on Patients and Families
CBSSM Seminar with Allison Kurian, MD, MSc Associate Professor Departments of Medicine (Oncology) and of Health Research & Policy Director, Women’s Clinical Cancer Genetics Program Stanford University School of Medicine
May 7, 2019
3:00 pm - 4:00 pm
NCRC, Building 16, 266C
Sponsored by: Center for Bioethics and Social Sciences in Medicine
Contact Information: Kerry Ryan kryanz@umich.edu
Abstract: Next-generation sequencing technology has made genetic testing for cancer risk more comprehensive, faster and cheaper than ever before. Yet questions remain about the impact of widespread genetic testing on cancer patients and their relatives, in terms of treatment decision-making and quality of life. I will discuss recent progress and ongoing research in this area.